Risk factors for cytomegalovirus reactivation in autoimmune bullous disease patients on immunosuppressive therapy

Australas J Dermatol. 2021 May;62(2):e343-e344. doi: 10.1111/ajd.13528. Epub 2021 Jan 13.

Authors

Yumi Aoyama^{1

2}, Seiko Sugiyama^{1

2}, Chieko Katayama^{1

2}, Koji Kamiya³

Affiliations

¹ Department of Dermatology, Kawasaki General Medical Center, Kawasaki Medical School, Okayama, Japan.
² Department of Dermatology, Kawasaki Medical School, Kurashiki, Japan.
³ Department of Dermatology, Jichi Medical University, Shimotsuke, Japan.

PMID: 33438199
DOI: 10.1111/ajd.13528

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Antiviral Agents / therapeutic use
Blister / complications*
Blister / drug therapy
Cytomegalovirus / pathogenicity*
Cytomegalovirus Infections / complications*
Cytomegalovirus Infections / epidemiology
Female
Ganciclovir / therapeutic use
Humans
Immunosuppression Therapy / adverse effects
Immunosuppression Therapy / methods
Latent Infection / diagnosis*
Male
Middle Aged
Risk Factors

Substances

Antiviral Agents
Ganciclovir

Grants and funding